| Pharmaceutical active ingredients: |
| Nalidixic Acid |
| Available forms, composition and doses of Diarlop Suspension: |
| Suspension; Oral; Nalidixic Acid 300 mg / 5 ml |
| Diarlop Suspension medical category: |
| Human:QuinolonesUrinary antiseptics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01MB02 - Nalidixic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Jagson Pal Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Asthmino | Ephedrine Hydrochloride; Phenobarbital; Theophylline | Jagson Pal Pharmaceuticals |
| Consec | Ranitidine Hydrochloride | Jagson Pal Pharmaceuticals |
| Diarlop Capsules | Loperamide Hydrochloride | Jagson Pal Pharmaceuticals |
| Diarlop Plus Capsules | Loperamide Hydrochloride | Jagson Pal Pharmaceuticals |
| Diarlop Plus Suspension | Metronidazole; Nalidixic Acid | Jagson Pal Pharmaceuticals |
| Diarlop-CT | Ciprofloxacin; Tinidazole | Jagson Pal Pharmaceuticals |
| Doflex | Diclofenac Sodium | Jagson Pal Pharmaceuticals |
| Doxypal-DR | Doxycycline Hyclate | Jagson Pal Pharmaceuticals |
| Equilibrium | Chlordiazepoxide | Jagson Pal Pharmaceuticals |
| Equirex | Chlordiazepoxide; Clidinium Bromide | Jagson Pal Pharmaceuticals |